Cita APA

Shiffman, D., Perez, M. V., Bare, L. A., Louie, J. Z., Arellano, A. R., & Devlin, J. J. (2015). Genetic risk for atrial fibrillation could motivate patient adherence to warfarin therapy: A cost effectiveness analysis. BMC Cardiovasc Disord.

Citación estilo Chicago

Shiffman, Dov, Marco V. Perez, Lance A. Bare, Judy Z. Louie, Andre R. Arellano, y James J. Devlin. "Genetic Risk for Atrial Fibrillation Could Motivate Patient Adherence to Warfarin Therapy: A Cost Effectiveness Analysis." BMC Cardiovasc Disord 2015.

Cita MLA

Shiffman, Dov, et al. "Genetic Risk for Atrial Fibrillation Could Motivate Patient Adherence to Warfarin Therapy: A Cost Effectiveness Analysis." BMC Cardiovasc Disord 2015.